However, not everyone responds equally to GLP-1 therapy, and joint pain relief depends on multiple factors including baseline inflammatory status, genetic regulation of appetite and metabolism, and overall musculoskeletal health
CrossRef Risk Factors for Liver Fibrosis in Patients with Type 2 Diabetes Mellitus and Metabolic DysfunctionAssociated Steatotic Liver Disease in Brazzaville Farel Elilie Mawa Ongoth, Rudel Godrche Kondo, Philestine Clausina Mikoll Ahoui Apendi, Nestor Ghislain Andzouana Mbamognoua, Rassa Laure Mayanda Ohouana, Aymande Okoumou-Moko, Ornella Marline Yvonne Dinghat, Jol Rudy Ekoundzola, Svrin Nkoua Eloi, Open Journal of Endocrine and Metabolic Diseases .2025
The most commonly reported side effects of weight loss injectionsnausea, vomiting, and diarrhoeaare gastrointestinal rather than hepatic in nature
The Pipeline Takeaway: The next 2436 months will likely introduce two to three new approvals offering superior efficacy, oral delivery options, or much better body composition outcomes
